GERMAIN MARK bought SCNI
June 16, 2026 · Form 4 insider transaction
GERMAIN MARK bought 120,000,000 shares of Scinai Immunotherapeutics Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
120,000,000
Price
$0.00
Total value
N/A
InsiderGERMAIN MARK
Role—
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateJune 16, 2026
Filing dateJune 18, 2026
Shares owned after120,000,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Ordinary Shares are no par value per share, and are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares.; Includes 120,000,000 Ordinary Shares represented by restricted share units granted on June 16, 2026, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates.